Study Claims Ozempic Lowers Biological Age
Researchers reveal that GLP-1 medication Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
GLP-1 medications have proven to be incredibly versatile, originally developed as a treatment for diabetes, and later used for treating obesity and promoting weight loss.
A recent study by TruDiagnostic, a 32-week, double-blind, placebo-controlled trial, suggests that Ozempic may reduce the user’s biologic age by just over three years.
Ozempic may reduce biological age, offering new hope in the fight against aging and related health issues.
The positive impact on weight-management makes the drugs helpful in treating conditions associated or impacted by obesity.
Author's summary: Ozempic reduces biological age.
More News
- Remedy-Kayne Anderson JV to Pay $7.2B for Medical Outpatient Portfolio
- Trump administration quietly purges ICE leaders in five cities, including Denver: Sources
- From WNBA Court To Playmate Glam: Check Out Kysre Gondrezick’s Sexiest Photos
- Eintracht Frankfurt Borussia Dortmund 28 10 2025 Live Score and Match Summary
- OpenAI completes for-profit shift, gives Microsoft 27% stake
- Who is Buying Ultra-Luxury Properties in Hyderabad?
- Al Nassr Al-Ittihad Jeddah 28 10 2025 Live Score and Match Summary
- Atalanta v AC Milan: Confirmed line-ups as Rossoneri look to end hosts' unbeaten start
- Kieran McKenna Linked with Celtic Job
- Windy day/Evening cold front